NCT05510856View on ClinicalTrials.gov

Comparative Clinical Study Evaluating the Possible Efficacy of Duloxetine, Gabapentin and Lacosamide on Oxaliplatin-Induced Peripheral Neuropathy in Cancer Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

September 30, 2024

Study Completion Date

October 15, 2024

Conditions
Oncology
Interventions
OTHER

Duloxetine

Duloxetine 30mg / day for 12 cycles (up to 6 months)

OTHER

Gabapentin

Gabapentin 300 mg / day for 12 cycles (up to 6 months)

OTHER

Lacosamide

Lacosamide 50 mg / day for 12 cycles (up to 6 months)

Trial Locations (1)

040

Oncology Department, Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER